Without knowing with certainty whether BC/GC and other non-neuronal cells in FCDIIb and TSC are protective or deleterious, targeting these cells specifically or the mTOR pathway in general, the possible outcomes are difficult to predict. This evidence concerns the gene TSC1 and breast cancer.